➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
AstraZeneca
McKesson
Baxter
Boehringer Ingelheim

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PF-06372865

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for PF-06372865?

PF-06372865 is an investigational drug.

There have been 10 clinical trials for PF-06372865. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Disease, Anxiety Disorders, and Low Back Pain. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There is one US patent protecting this investigational drug and forty-eight international patents.

Recent Clinical Trials for PF-06372865
TitleSponsorPhase
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy SubjectsPfizerPhase 1
PF-06372865 in Subjects With Photosensitive EpilepsyPfizerPhase 2
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy SubjectsPfizerPhase 1

See all PF-06372865 clinical trials

Clinical Trial Summary for PF-06372865

Top disease conditions for PF-06372865
Top clinical trial sponsors for PF-06372865

See all PF-06372865 clinical trials

International Patents for PF-06372865

Drugname Country Document Number Estimated Expiration Related US Patent
PF-06372865 Argentina 093937 2032-12-14   Start Trial
PF-06372865 Australia 2013356894 2032-12-14   Start Trial
PF-06372865 Brazil 112015014097 2032-12-14   Start Trial
PF-06372865 Canada 2892174 2032-12-14   Start Trial
PF-06372865 Chile 2015001652 2032-12-14   Start Trial
PF-06372865 China 104837843 2032-12-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
AstraZeneca
McKesson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.